Lyoble 15IU Injection

About

Menotropins, also known as human menopausal gonadotropin (hMG), is a pharmaceutical preparation containing a mixture of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity, extracted from the urine of postmenopausal women. This gonadotropin combination is crucial in reproductive medicine for stimulating ovarian follicular development in women undergoing assisted reproductive technologies (ART) or for inducing ovulation in anovulatory women. In women, FSH stimulates the growth of ovarian follicles, while LH is essential for follicular maturation, steroidogenesis, and ovulation. In men, menotropins can be used in conjunction with human chorionic gonadotropin (hCG) to stimulate spermatogenesis in cases of hypogonadotropic hypogonadism. The dosage and administration are highly individualized, requiring close monitoring of ovarian response to minimize risks such as ovarian hyperstimulation syndrome (OHSS) and multiple pregnancies.

Uses

• Induction of ovulation in anovulatory women
• Stimulation of follicular development in ART
• Treatment of male hypogonadotropic hypogonadism
• Stimulation of spermatogenesis

Directions For Use

Administered subcutaneously or intramuscularly by a healthcare professional. Dosage is individualized and requires careful monitoring.

Benefits

• Stimulates ovarian follicle growth
• Induces ovulation
• Effective in various infertility cases
• Can be used in men for spermatogenesis
• Improves chances of conception
• Well-established fertility treatment

Side Effects

• Ovarian hyperstimulation syndrome (OHSS)
• Abdominal pain
• Headache
• Nausea
• Breast tenderness
• Injection site reactions
• Multiple pregnancies
• Ectopic pregnancy
• Ovarian cysts
• Mood swings
• Fatigue
• Rash

Safety Measures

• Alcohol - No specific contraindication, but moderation is generally advised during fertility treatments.
• Pregnancy - Not applicable as it's used to achieve pregnancy; discontinue once pregnancy is confirmed.
• Breastfeeding - Not recommended during breastfeeding as it may suppress lactation and its effects on the infant are unknown.
• Liver - Use with caution in patients with severe liver impairment; monitor closely.
• Kidney - Use with caution in patients with severe renal impairment; monitor closely.
• Lung - Monitor for pulmonary complications, especially in cases of severe OHSS (e.g., pleural effusion).

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.